BioLineRx (BLRX) PT Raised to $22 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on BioLineRx (NASDAQ: BLRX) to $22.00 while maintaining a Buy rating.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
